Navigating Career Changes in Biology

But after 15 years in academic research, I’m considering a shift to industry and feeling a bit lost… Does anyone have experiences or advice on transitioning from academia to a biotech company? It seems daunting, but I know many have made the leap successfully. I’d love to hear your stories or tips?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​‍‌‍‍‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌​​⁠​​​⁠‌‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​​‌‌‍‌⁠‌​‌⁠‌​‌‌‌‌​⁠​⁠​⁠​⁠‌‌‌‌‌​​⁠‌‌​⁠‌⁠‌‍⁠⁠‌‍‍​‌⁠‌‌‌‌‍‌‌⁠‍‍‌‍‍⁠​‍​‍‌⁠⁠‌​

making a switch after 15 years is no small feat! A solid tip is to network with former colleagues who made the jump; they often have insights into what biotech companies look for. I recommend exploring online networking events or industry meetups; sometimes just knowing someone in the field can ease that daunting feeling.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​‍‌‍‍‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‌‍​⁠‍‌​⁠‍‌​⁠​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌​​⁠​​​⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌‌⁠‌​‍‍‌⁠​​​⁠‌⁠‌​‌‌‌⁠‌​‌​​‍‌​⁠​​⁠​‌‌​⁠‌‌⁠‌‌‌‌‍​‌‌‍‍‌‌‍‍‌​​‌​⁠‍‌​‍​‍‌⁠⁠‌

It can help to focus on the transferable skills you’ve gained in academia, like problem-solving and critical thinking. I found it useful to tailor my CV to highlight these, and connecting with recruiters in the biotech space can also open up opportunities. Have you thought about what specific roles you might be interested in?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​‍‌‍‍‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‌‍​⁠‍‌​⁠‍‌​⁠​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌​​⁠​‌​⁠​‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​‌‍‌⁠‌⁠‌​‍⁠​⁠‌⁠​⁠‌⁠‌⁠‌‌‌⁠‌‍‌​‌‌‌​⁠‍​⁠‌⁠​⁠‌‌‌‍​‍‌‍​‌‌​⁠‌‌​‌⁠​‍⁠‌​‍​‍‌⁠⁠‌

But i get how overwhelming it’s going from 15 years in academia to industry. I was in a similar boat and found that doing a few informational interviews with people at biotech firms really helped. It’s a chance to understand what they value and can also help ease some of that uncertainty.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​‍‌‍‍‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‌‍​⁠‍‌​⁠‍‌​⁠​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌​​⁠​‌​⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌‍‌​‍⁠‌‌‌‍‍​⁠‌‍‌‌​⁠‌​⁠‌‌‍‍‍‌⁠‌‌​⁠​‌‌‌‌​‌​⁠⁠‌⁠‍‌‌‍‌​​⁠‌⁠‌‌‍‌‌⁠‍‌​‍​‍‌⁠⁠‌